Vizsgálati helyszín
Endeavor Clinical Trials
San Antonio, Texas 78240, Egyesült ÁllamokMég nincs intézményhez kötve
- 13futó vizsgálat
- 16lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 29 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 2. fázis13 vizsgálat
- 1. fázis7 vizsgálat
- 3. fázis7 vizsgálat
- 1/2. fázis1 vizsgálat
- Állapot
- Lezárult14 vizsgálat
- Fut, nem toboroz6 vizsgálat
- Toboroz6 vizsgálat
- Még nem toboroz1 vizsgálat
- Leállították1 vizsgálat
- Visszavonták1 vizsgálat
- Fő szponzor
- Eli Lilly and Company14 vizsgálat
- Boehringer Ingelheim2 vizsgálat
- Regeneron Pharmaceuticals2 vizsgálat
- Alveus Therapeutics, Inc.1 vizsgálat
- Amgen1 vizsgálat
- és még 9
Futó vizsgálatok
Még nem toboroz
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes
NCT07890376· 2. fázis· Eli Lilly and Company· Forrás
Contact: Nitendra Agarwal (principal investigator)
Fut, nem toboroz
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
NCT07477704· 2. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
NCT07589608· 2. fázis· Eli Lilly and Company· Forrás
Contact: Nitendra Agarwal (principal investigator)
Toboroz
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
NCT07392190· 3. fázis· Eli Lilly and Company· Forrás
Contact: Nitendra Agarwal (principal investigator)
Toboroz
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
NCT07353931· 3. fázis· Eli Lilly and Company· Forrás
Contact: Nitendra Agarwal (principal investigator)
Fut, nem toboroz
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
NCT07399678· 1. fázis· Alveus Therapeutics, Inc.· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
NCT07122700· Foundation for the National Institutes of Health· Forrás
Contact: Emanuel De Noia, MD
Fut, nem toboroz
53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
NCT06865079· 2. fázis· OrthoTrophix, Inc· Forrás
Fut, nem toboroz
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
NCT06637371· 1. fázis· Amgen· Forrás
Fut, nem toboroz
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
NCT06383390· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
NCT06143956· 2. fázis· Eli Lilly and Company· Forrás
Contact: Nitendra Agarwal (principal investigator)
Fut, nem toboroz
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
NCT05030428· 3. fázis· Novartis Pharmaceuticals· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Toboroz
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
NCT07269210· 2. fázis· Eli Lilly and Company· Forrás
Toboroz
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
NCT07213778· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Leállították
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
NCT07030868· 2. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
NCT06945419· 1. fázis· Eli Lilly and Company· Forrás
Lezárult
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
NCT06737042· 2. fázis· Gan and Lee Pharmaceuticals, USA· Forrás
Lezárult
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
NCT06824051· 1. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
NCT06683508· 2. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
NCT06603571· 2. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
NCT06230523· 2. fázis· Eli Lilly and Company· Forrás
Lezárult
Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia
NCT06056570· 1/2. fázis· Urica Therapeutics Inc.· Forrás
Lezárult
A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
NCT05970640· 1. fázis· Boehringer Ingelheim· Forrás
Lezárult
Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
NCT05745883· 1. fázis· Disc Medicine, Inc· Forrás
Lezárult
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
NCT05542264· 1. fázis· Otsuka Pharmaceutical Development & Commercialization, Inc.· Forrás
Lezárult
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
NCT05327127· 2. fázis· Kowa Research Institute, Inc.· Forrás
Lezárult
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
NCT05586958· 3. fázis· LG Chem· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
NCT04166773· 2. fázis· Eli Lilly and Company· Forrás
Hibát jelzek